1-6 of 6
Robert Maki
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma

Sujana Movva, Kenneth Seier, Viswatej Avutu, Lauren B. Banks, Jason Chan, Ping Chi, Mark A. Dickson, Mrinal M. Gounder, Ciara M. Kelly, Mary L. Keohan, Robert Maki, Evan Rosenbaum, Tiffany Salcito, Kaithleen Rodriguez, Rebecca Dempsey, Paul A. Meyers, Seth M. Cohen, Martee L. Hensley, Jason A. Konner, Alison M. Schram, Robert A. Lefkowitz, Joseph P. Erinjeri, Li-Xuan Qin, William D. Tap, Sandra P. D’Angelo
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (24): 5612–5619.
https://doi.org/10.1158/1078-0432.CCR-24-2519
Published: 16 December 2024
View article titled, Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma
Open the PDF for Histology-Specific Clinical Trial of Lenvatinib and Pembrolizumab in Patients with Sarcoma in another window
Includes: Supplementary data
Journal Articles

Abstract B40: Mouse clinical trials: integrating PDX models of sarcoma subtypes with genomics to replicate patient responses to cancer therapeutics

Amanda Katz, Raphael E. Pollock, Leonard H. Wexler, Carlos Rodriguez-Galindo, Jonathan C. Trent, Robert Maki, Jennifer Jaskowiak, Lindsay Ryland, Daniel Ciznadija, Angela Davies, Keren Paz
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (16_Supplement): B40.
https://doi.org/10.1158/1557-3265.PDX16-B40
Published: 15 August 2016
View article titled, Abstract B40: Mouse clinical trials: integrating PDX models of sarcoma subtypes with genomics to replicate patient responses to cancer therapeutics
Journal Articles

DNA repair efficiency as a model for personalized therapy with Trabectedin

Rafael Rosell, Federica Grosso, Patrick Schoffski, Paolo Casali, Robert Maki, Miquel Taron, Pedro Mendez, Imane Chaib, Antonio Nieto, Juan Carlos Tercero, Robin Jones, Ian Judson, Jean-Yves Blay, Axel Lecesne, Jose Jimeno
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (19_Supplement): A57.
Published: 15 August 2014
View article titled, DNA repair efficiency as a model for personalized therapy with Trabectedin
Journal Articles

A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors

Archie N. Tse, David S. Klimstra, Mithat Gonen, Manish Shah, Tahir Sheikh, Rachel Sikorski, Richard Carvajal, Janet Mui, Caroll Tipian, Eileen O'Reilly, Ki Chung, Robert Maki, Robert Lefkowitz, Karen Brown, Katia Manova-Todorova, Nian Wu, Merrill J. Egorin, David Kelsen, Gary K. Schwartz
Journal: Clinical Cancer Research
Clin Cancer Res (2008) 14 (20): 6704–6711.
https://doi.org/10.1158/1078-0432.CCR-08-1006
Published: 16 October 2008
View article titled, A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors
Open the PDF for A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors in another window
Includes: Supplementary data
Journal Articles

Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor

Anat Norden-Zfoni, Jayesh Desai, Judith Manola, Paul Beaudry, Jeremy Force, Robert Maki, Judah Folkman, Carlo Bello, Charles Baum, Sam E. DePrimo, David R. Shalinsky, Goerge D. Demetri, John V. Heymach
Journal: Clinical Cancer Research
Clin Cancer Res (2007) 13 (9): 2643–2650.
https://doi.org/10.1158/1078-0432.CCR-06-0919
Published: 01 May 2007
View article titled, Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor
Open the PDF for Blood-Based Biomarkers of SU11248 Activity and Clinical Outcome in Patients with Metastatic Imatinib-Resistant Gastrointestinal Stromal Tumor in another window
Journal Articles

Association of KIT Exon 9 Mutations with Nongastric Primary Site and Aggressive Behavior: KIT Mutation Analysis and Clinical Correlates of 120 Gastrointestinal Stromal Tumors

Cristina R. Antonescu, Gunhild Sommer, Lisa Sarran, Sylvia J. Tschernyavsky, Elyn Riedel, James M. Woodruff, Mark Robson, Robert Maki, Murray F. Brennan, Marc Ladanyi, Ronald P. DeMatteo, Peter Besmer
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3329–3337.
Published: 05 September 2003
View article titled, Association of <em>KIT</em> Exon 9 Mutations with Nongastric Primary Site and Aggressive Behavior: <subtitle> <em>KIT</em> Mutation Analysis and Clinical Correlates of 120 Gastrointestinal Stromal Tumors</subtitle>
Open the PDF for Association of <em>KIT</em> Exon 9 Mutations with Nongastric Primary Site and Aggressive Behavior: <subtitle> <em>KIT</em> Mutation Analysis and Clinical Correlates of 120 Gastrointestinal Stromal Tumors</subtitle> in another window